Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BLFS BioLife Solutions, Inc. daily Stock Chart
BLFS [NASD]
BioLife Solutions, Inc.
Healthcare | Medical Instruments & Supplies | USA
statements
Index- P/E28.18 EPS (ttm)0.68 Insider Own2.00% Shs Outstand21.01M Perf Week9.30%
Market Cap566.03M Forward P/E64.07 EPS next Y0.30 Insider Trans130.32% Shs Float15.00M Perf Month27.12%
Income16.30M PEG2.82 EPS next Q-0.04 Inst Own48.00% Short Float7.51% Perf Quarter84.45%
Sales33.80M P/S16.75 EPS this Y94.50% Inst Trans14.81% Short Ratio4.17 Perf Half Y19.53%
Book/sh3.22 P/B5.97 EPS next Y-43.82% ROA20.10% Target Price22.38 Perf Year18.72%
Cash/sh- P/C- EPS next 5Y10.00% ROE27.80% 52W Range7.37 - 21.18 Perf YTD18.79%
Dividend- P/FCF5660.29 EPS past 5Y22.70% ROI26.30% 52W High-9.25% Beta1.52
Dividend %- Quick Ratio0.60 Sales past 5Y34.60% Gross Margin65.40% 52W Low160.79% ATR1.23
Employees151 Current Ratio1.00 Sales Q/Q110.30% Oper. Margin29.00% RSI (14)67.17 Volatility6.48% 7.43%
OptionableYes Debt/Eq0.00 EPS Q/Q185.10% Profit Margin48.20% Rel Volume1.21 Prev Close19.40
ShortableYes LT Debt/Eq0.00 EarningsMay 14 AMC Payout0.00% Avg Volume269.82K Price19.22
Recom1.70 SMA2013.14% SMA5021.06% SMA20030.11% Volume327,127 Change-0.93%
Jul-08-20Reiterated Maxim Group Buy $18 → $26
Feb-24-20Initiated Lake Street Buy $25
Feb-19-20Initiated The Benchmark Company Buy $24
Feb-06-20Resumed B. Riley FBR Buy $27
Jan-08-20Initiated Stephens Overweight $23
Nov-21-19Initiated Oppenheimer Outperform $22
Jul-22-19Initiated H.C. Wainwright Buy $23
Nov-10-17Reiterated Maxim Group Buy $7 → $8
Sep-19-17Reiterated Maxim Group Buy $6 → $7
Jul-05-17Upgrade Janney Neutral → Buy $5
Mar-10-17Reiterated Maxim Group Buy $3 → $4
Jan-19-17Initiated Maxim Group Buy $3
Jul-07-20 12:45PM  
BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock
PR Newswire
Jul-06-20 09:08AM  
Moving Average Crossover Alert: BioLife Solutions
Zacks
06:57AM  
BioLife (BLFS) Catches Eye: Stock Jumps 12.1%
Zacks
Jul-02-20 02:48PM  
Here's Why BioLife Solutions Jumped Higher Today
Motley Fool +12.09%
07:40AM  
BioLife Solutions Announces Pricing of $75 Million Public Offering of Common Stock
PR Newswire
12:40AM  
Edited Transcript of BLFS.OQ earnings conference call or presentation 14-May-20 8:30pm GMT
Thomson Reuters StreetEvents
Jul-01-20 04:02PM  
BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020
PR Newswire
04:01PM  
BioLife Solutions Announces Proposed Public Offering of Common Stock
PR Newswire
Jun-26-20 11:45AM  
Is BioLife Solutions, Inc. (BLFS) A Good Stock To Buy?
Insider Monkey
May-18-20 04:15PM  
BioLife Solutions Promotes Marcus Schulz to Vice President, Global Sales
PR Newswire
May-14-20 08:30PM  
Biolife Solutions Inc (BLFS) Q1 2020 Earnings Call Transcript
Motley Fool
04:05PM  
BioLife Solutions Announces First Quarter 2020 Financial Results
PR Newswire
May-13-20 12:52PM  
CytoDyn (CYDY) to Report Q4 Earnings: What's in the Cards?
Zacks
10:20AM  
Why Earnings Season Could Be Great for BioLife Solutions (BLFS)
Zacks
May-11-20 08:00AM  
BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020
PR Newswire +9.40%
May-01-20 08:00AM  
BioLife Solutions Announces Preliminary First Quarter 2020 Revenue
PR Newswire
Apr-20-20 06:44AM  
Is BioLife Solutions, Inc. (NASDAQ:BLFS) A Volatile Stock?
Simply Wall St.
Mar-30-20 06:35PM  
Edited Transcript of BLFS earnings conference call or presentation 11-Mar-20 8:30pm GMT
Thomson Reuters StreetEvents
Mar-28-20 08:45AM  
How Does BioLife Solutions's (NASDAQ:BLFS) P/E Compare To Its Industry, After The Share Price Drop?
Simply Wall St.
Mar-14-20 08:58AM  
Did You Miss BioLife Solutions's (NASDAQ:BLFS) Whopping 428% Share Price Gain?
Simply Wall St.
08:38AM  
How Does BioLife Solutions's (NASDAQ:BLFS) P/E Compare To Its Industry, After The Share Price Drop?
Simply Wall St.
Mar-11-20 04:29PM  
BioLife Solutions Announces Fourth Quarter and Full Year 2019 Financial Results
PR Newswire -7.20%
02:30PM  
BioLife Solutions, Inc. to Host Earnings Call
ACCESSWIRE
Feb-17-20 06:14AM  
What Does BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Indicate?
Simply Wall St.
Feb-12-20 08:00AM  
BioLife Solutions Announces Earnings Call Date and Upcoming Investor and Scientific Conferences
PR Newswire
Feb-07-20 07:46AM  
Analysts Back a Turnaround at BioLife Solutions
Investopedia
Jan-22-20 05:46AM  
Here's Why We Think BioLife Solutions (NASDAQ:BLFS) Is Well Worth Watching
Simply Wall St.
Jan-04-20 07:25AM  
Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT
Thomson Reuters StreetEvents
Dec-30-19 11:35AM  
How Much Did BioLife Solutions, Inc.'s (NASDAQ:BLFS) CEO Pocket Last Year?
Simply Wall St.
Dec-26-19 08:13PM  
What could you have made by investing $1,000 in these Washington companies a decade ago?
American City Business Journals
Dec-19-19 09:26PM  
Smart Money Dumping BioLife Solutions, Inc. (BLFS)
Insider Monkey
Dec-04-19 06:58AM  
Can BioLife Solutions, Inc. (NASDAQ:BLFS) Maintain Its Strong Returns?
Simply Wall St.
Dec-02-19 08:00AM  
BioLife Solutions Announces Executive Appointments to Support Integration of Acquired Companies
PR Newswire -5.85%
Nov-22-19 03:01AM  
Seattle has potential as a biotech hub, but more companies must stay here and grow
American City Business Journals
Nov-12-19 04:03PM  
BioLife Solutions Acquires Custom Biogenic Systems
PR Newswire
04:01PM  
BioLife Solutions Announces Third Quarter 2019 Financial Results
PR Newswire
Nov-11-19 08:07AM  
Is BioLife Solutions, Inc. (NASDAQ:BLFS) Creating Value For Shareholders?
Simply Wall St.
Nov-07-19 06:15PM  
BioLife Solutions, Inc. (BLFS): Hedge Fund Interest Cooling Off
Insider Monkey
08:00AM  
BioLife Solutions Named one of the Fastest Growing Companies in North America on Deloitte's 2019 Technology Fast 500
PR Newswire
Oct-31-19 08:23PM  
BioLife Solutions to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019
PR Newswire
Oct-22-19 09:13AM  
Medical Products Industry Outlook: Prospects Seem Promising
Zacks
Oct-14-19 09:41AM  
A Quick Look at 2 Positive Looking Biotech Plays
TheStreet.com +6.44%
08:00AM  
BioLife Solutions Awarded Three New Patents for Cryopreservation, Thawing and Cold Chain Transport Technologies
PR Newswire
Sep-24-19 08:00AM  
iVexSol Announces $2M in Seed Funding
GlobeNewswire -11.29%
08:00AM  
BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator
PR Newswire
Sep-16-19 08:00AM  
BioLife Solutions Announces New evo® Cold Chain Customers
PR Newswire
Sep-11-19 10:15PM  
Biolife Solutions Inc (BLFS) President & CEO Michael Rice Sold $553,992 of Shares
GuruFocus.com
Sep-06-19 10:15PM  
Biolife Solutions Inc (BLFS) CFO Greef Roderick De Sold $593,400 of Shares
GuruFocus.com
Sep-03-19 12:30PM  
Edited Transcript of BLFS earnings conference call or presentation 8-Aug-19 8:30pm GMT
Thomson Reuters StreetEvents
08:00AM  
Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution
PR Newswire
Aug-28-19 08:00AM  
BioLife Solutions Strengthens Sales Team with Key Leadership Additions
PR Newswire
Aug-12-19 08:00AM  
BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences
PR Newswire
Aug-08-19 11:23PM  
Biolife Solutions Inc (BLFS) Q2 2019 Earnings Call Transcript
Motley Fool
04:05PM  
BioLife Solutions Announces Second Quarter 2019 Financial Results
PR Newswire
08:05AM  
BioLife Solutions Completes Acquisition of SAVSU Technologies
PR Newswire
Aug-02-19 10:15PM  
Biolife Solutions Inc (BLFS) CFO Greef Roderick De Sold $568,800 of Shares
GuruFocus.com -5.11%
Aug-01-19 10:33AM  
BioLife Solutions (BLFS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
Jul-31-19 08:00AM  
BioLife Solutions to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019
PR Newswire
Jul-30-19 08:00AM  
SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies
PR Newswire
Jul-23-19 08:00AM  
SAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene Therapies
PR Newswire
Jul-08-19 04:31PM  
ABQ biotech firm to be acquired
American City Business Journals +15.91%
Jun-23-19 09:45PM  
Hedge Funds Have Never Been This Bullish On BioLife Solutions, Inc. (BLFS)
Insider Monkey
Jun-10-19 08:00AM  
BioLife Solutions to Join Russell 3000® Index
PR Newswire
May-30-19 08:00AM  
BioLife Solutions to Present at the Jefferies 2019 Healthcare Conference
PR Newswire
May-29-19 08:00AM  
BioLife Solutions Announces SAVSU Technologies Selected by Novartis to Supply Advanced Cold Chain Management Platform for Newly Approved Gene Therapy
PR Newswire
May-22-19 12:54PM  
Edited Transcript of BLFS earnings conference call or presentation 9-May-19 8:30pm GMT
Thomson Reuters StreetEvents
May-09-19 08:24PM  
Biolife Solutions Inc (BLFS) Q1 2019 Earnings Call Transcript
Motley Fool
04:05PM  
BioLife Solutions Announces First Quarter 2019 Financial Results
PR Newswire
May-02-19 10:32AM  
BioLife Solutions (BLFS) to Report Q1 Results: Wall Street Expects Earnings Growth
Zacks
08:00AM  
BioLife Solutions to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019
PR Newswire
Apr-02-19 08:00AM  
BioLife Solutions Completes Acquisition of Astero Bio
PR Newswire
Mar-25-19 11:40AM  
Can BioLife Solutions, Inc. (NASDAQ:BLFS) Improve Its Returns?
Simply Wall St.
Mar-20-19 08:08AM  
Edited Transcript of BLFS earnings conference call or presentation 14-Mar-19 8:30pm GMT
Thomson Reuters StreetEvents
Mar-15-19 11:48PM  
BioLife Solutions Inc (BLFS) Files 10-K for the Fiscal Year Ended on December 31, 2018
GuruFocus.com +5.71%
Mar-14-19 08:26PM  
Biolife Solutions Inc (BLFS) Q4 2018 Earnings Conference Call Transcript
Motley Fool
04:05PM  
BioLife Solutions Announces Fourth Quarter and Full Year 2018 Financial Results
PR Newswire
08:00AM  
BioLife Solutions Expands Cell and Gene Therapy Tools Portfolio with Acquisition of Astero Bio
PR Newswire
Mar-04-19 08:00AM  
BioLife Solutions to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 14, 2019
PR Newswire -10.25%
Feb-19-19 08:00AM  
BioLife Solutions to Attend and Present at Upcoming Investor and Scientific Conferences
PR Newswire +7.74%
Feb-08-19 08:57AM  
Here's Why You Should Invest in Stryker (SYK) Stock Right Now
Zacks
Jan-29-19 04:10PM  
Medical Products Industry Outlook: Plenty of Upside Left
Zacks
Jan-22-19 09:58AM  
SAVSU Technologies Launches Two New evo® Smart Shipper Models to Improve Apheresis Collection Shipments and Cryopreserved Cell and Gene Therapies
PR Newswire
08:00AM  
New Policies to Advance Development of Cell and Gene Therapies Announced by FDA
PR Newswire
Jan-11-19 08:53AM  
Medical Products Industry Gathering Steam: 3 Stocks to Buy
Zacks
Dec-11-18 08:00AM  
Consolidated Research: 2018 Summary Expectations for Enbridge Energy Partners, Sprouts Farmers Market, BioLife Solutions, PagSeguro Digital, NutriSystem, and Employers Fundamental Analysis, Key Performance Indications
GlobeNewswire
Dec-07-18 02:20PM  
Edited Transcript of BLFS earnings conference call or presentation 8-Nov-18 9:30pm GMT
Thomson Reuters StreetEvents -7.07%
Nov-27-18 08:00AM  
BioLife Solutions Completes Redemption of Series A Preferred Stock
PR Newswire
Nov-13-18 08:00AM  
BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences
PR Newswire
Nov-08-18 04:05PM  
BioLife Solutions Announces Third Quarter 2018 Financial Results
PR Newswire
Nov-05-18 08:08AM  
BioLife (BLFS) to Report Q3 Earnings: What's in the Cards?
Zacks
08:00AM  
SAVSU Technologies to Supply evo® Cold Chain Technologies to AveXis
PR Newswire
Nov-01-18 08:00AM  
BioLife Solutions to Report Third Quarter 2018 Financial Results and Provide Business Update on November 8, 2018
PR Newswire
Oct-18-18 07:40AM  
Market Trends Toward New Normal in Rambus, GMS, Advanced Energy Industries, AZZ, BioLife Solutions, and Spartan Motors Emerging Consolidated Expectations, Analyst Ratings
GlobeNewswire
Oct-03-18 06:57AM  
BioLife Solutions Sees Hammer Chart Pattern: Time to Buy?
Zacks -15.87%
Oct-01-18 08:00AM  
BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year
PR Newswire
Sep-27-18 09:30AM  
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?
Zacks
Sep-05-18 04:31PM  
Local bioscience firm nets $5 million investment
American City Business Journals -14.12%
08:00AM  
BioLife Solutions Increases Ownership in SAVSU Technologies to 44% with $5 Million Investment
PR Newswire
Sep-04-18 09:55AM  
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
Zacks
Aug-31-18 08:32AM  
Trump's Approval Rating Buoy Wall Street: 4 Top Gainers
Zacks
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VILLIGER WALTER10% OwnerJul 06Sale18.9723,372443,3674,971,179Jul 08 09:37 PM
Casdin Partners Master Fund, L10% OwnerJul 02Buy14.50305,5834,430,9545,840,107Jul 02 04:48 PM
VILLIGER WALTER10% OwnerJul 02Sale18.5717,088317,3244,994,551Jul 08 09:37 PM
GIRSCHWEILER THOMASDirectorJul 02Sale14.50305,5834,430,9541,642,774Jul 02 06:32 PM
Casdin Partners Master Fund, L10% OwnerJul 01Buy14.50685,0009,932,5005,534,524Jul 02 04:48 PM
Rice MichaelPresident & CEOJun 19Option Exercise2.0618,75038,625232,973Jun 23 08:00 PM
Rice MichaelPresident & CEOJun 19Sale16.3718,750306,938214,223Jun 23 08:00 PM
Rice MichaelPresident & CEOJun 11Option Exercise2.0618,75038,625232,973Jun 15 08:31 PM
Rice MichaelPresident & CEOJun 11Sale15.0118,750281,438214,223Jun 15 08:31 PM
Mathers JamesChief Revenue OfficerMay 28Sale16.871212,04119,856Jun 01 08:01 PM
Foster Karen A.Chief Quality OfficerMay 28Sale16.871702,86852,064Jun 01 08:02 PM
Rice MichaelPresident & CEOMay 28Sale16.875168,705214,223Jun 01 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 28Sale16.872424,083212,915Jun 01 08:01 PM
Casdin Partners Master Fund, L10% OwnerMay 22Buy10.50476,1915,000,0064,849,524May 26 01:54 PM
GIRSCHWEILER THOMASDirectorMay 22Sale10.50476,1915,000,0061,948,357Jun 03 08:00 PM
Rice MichaelPresident & CEOMay 15Option Exercise2.0618,75038,625233,489May 15 08:05 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 15Option Exercise2.0610,00020,600223,157May 15 08:04 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 15Sale14.2910,000142,900213,157May 15 08:04 PM
Rice MichaelPresident & CEOMay 15Sale14.2318,750266,813214,739May 15 08:05 PM
Casdin Partners Master Fund, L10% OwnerMay 14Buy10.501,904,76220,000,0014,373,333May 18 04:47 PM
Rice MichaelPresident & CEOMay 13Option Exercise2.0618,75038,625233,489May 15 08:05 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 13Option Exercise2.0610,00020,600223,157May 13 08:00 PM
Rice MichaelPresident & CEOMay 13Sale15.4518,750289,688214,739May 15 08:05 PM
VILLIGER WALTER10% OwnerMay 13Sale14.90631,1589,404,2544,526,236Jun 03 08:01 PM
GIRSCHWEILER THOMASDirectorMay 13Sale14.90492,2777,334,9272,424,548Jun 03 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 13Sale15.4210,000154,200213,157May 13 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 11Option Exercise2.0610,00020,600223,157May 13 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 11Sale13.4010,000134,000213,157May 13 08:00 PM
Rice MichaelPresident & CEOApr 15Option Exercise2.0618,75038,625233,489Apr 15 08:00 PM
Rice MichaelPresident & CEOApr 15Sale9.6618,750181,125214,739Apr 15 08:00 PM
Rice MichaelPresident & CEOApr 13Option Exercise2.0618,75038,625233,489Apr 15 08:00 PM
Rice MichaelPresident & CEOApr 13Sale9.0318,750169,313214,739Apr 15 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMar 24Sale9.2510,00092,500179,562Mar 26 08:00 PM
Rice MichaelPresident & CEOMar 12Option Exercise2.0618,75038,625184,574Mar 12 09:25 PM
Rice MichaelPresident & CEOMar 12Sale8.4418,750158,250165,824Mar 12 09:25 PM
Rice MichaelPresident & CEOMar 10Option Exercise2.0618,75038,625184,574Mar 12 09:25 PM
Rice MichaelPresident & CEOMar 10Sale12.1618,750228,000165,824Mar 12 09:25 PM
DE GREEF RODERICKCFO & COOMar 06Option Exercise1.8110,00018,10035,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 06Sale13.7710,000137,70025,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 05Option Exercise1.8110,00018,10035,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 05Sale13.7210,000137,20025,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 04Option Exercise1.8110,00018,10035,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 04Sale13.9510,000139,50025,859Mar 06 08:24 PM
Foster Karen A.Chief Quality OfficerFeb 26Sale15.0288413,27823,701Feb 28 08:12 PM
Rice MichaelPresident & CEOFeb 26Sale15.022,19032,894165,824Feb 28 08:12 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 26Sale15.021,02415,380189,562Feb 28 08:13 PM
Mathers JamesChief Revenue OfficerFeb 26Sale15.025087,63016,876Feb 28 08:14 PM
Rice MichaelPresident & CEOFeb 13Option Exercise2.0618,75038,625186,764Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 13Sale14.1718,750265,688168,014Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 11Option Exercise2.0618,75038,625186,764Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 11Sale13.6918,750256,688168,014Feb 13 09:36 PM
DE GREEF RODERICKCFO & COOFeb 07Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 07Sale13.3210,000133,20025,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 06Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 06Sale14.4310,000144,30025,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 05Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 05Option Exercise1.4017,96625,170200,586Feb 05 08:01 PM
DE GREEF RODERICKCFO & COOFeb 05Sale14.0610,000140,60025,859Feb 07 09:54 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 05Sale14.0610,000140,600190,586Feb 05 08:01 PM
Mathers JamesChief Revenue OfficerFeb 04Option Exercise1.642,1133,46519,497Feb 06 08:45 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Option Exercise1.4010,00014,010192,620Feb 05 08:01 PM
Mathers JamesChief Revenue OfficerFeb 04Sale14.032,11329,64517,384Feb 06 08:45 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Sale14.1010,000141,000182,620Feb 05 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 03Option Exercise1.4010,00014,010192,620Feb 05 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 03Sale13.6310,000136,300182,620Feb 05 08:01 PM
GIRSCHWEILER THOMASDirectorJan 30Option Exercise1.4010,71415,0101,524,677Feb 03 08:39 PM
Mathers JamesChief Revenue OfficerJan 23Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 23Sale15.112,50037,77517,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 22Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 22Sale15.682,50039,20017,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 21Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 21Sale15.692,50039,22517,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 09Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
Mathers JamesChief Revenue OfficerJan 09Sale16.762,50041,90017,384Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 08Option Exercise1.7610,00017,60035,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 08Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 08Sale16.1610,000161,60025,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 08Sale16.052,50040,12517,384Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 07Option Exercise1.7610,00017,60035,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 07Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 07Sale15.4610,000154,60025,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 07Sale15.732,50039,32517,384Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 06Option Exercise1.7610,00017,60035,859Jan 08 08:00 PM
DE GREEF RODERICKCFO & COOJan 06Sale15.9010,000159,00025,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerDec 27Option Exercise1.642,5004,10019,884Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 27Sale16.612,50041,52517,384Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 26Option Exercise1.642,5004,10019,884Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 26Sale16.512,50041,27517,384Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 24Option Exercise1.642,5004,10019,884Dec 27 08:00 PM
Mathers JamesChief Revenue OfficerDec 24Sale16.402,50041,00017,384Dec 27 08:00 PM
Berard ToddChief Marketing OfficerDec 16Option Exercise2.063,0006,18044,074Dec 18 08:00 PM
Berard ToddChief Marketing OfficerDec 16Sale15.683,00047,04041,074Dec 18 08:00 PM
Rice MichaelPresident & CEODec 12Option Exercise1.1210,24711,477178,261Dec 12 08:27 PM
Mathers JamesChief Revenue OfficerDec 12Option Exercise1.642,5004,10019,884Dec 12 09:17 PM
Rice MichaelPresident & CEODec 12Sale15.1110,247154,832168,014Dec 12 08:27 PM
Mathers JamesChief Revenue OfficerDec 12Sale15.002,50037,50017,384Dec 12 09:17 PM
Mathers JamesChief Revenue OfficerDec 11Option Exercise1.642,5004,10019,884Dec 12 09:17 PM
Mathers JamesChief Revenue OfficerDec 11Sale15.082,50037,70017,384Dec 12 09:17 PM
Rice MichaelPresident & CEODec 10Option Exercise1.1210,00011,200178,014Dec 12 08:27 PM
Mathers JamesChief Revenue OfficerDec 10Option Exercise1.642,5004,10019,884Dec 12 09:17 PM
open in yahoo | open in reuters | open in google